The CH1α domain of mucosal gp41 IgA contributes to antibody specificity and antiviral functions in HIV-1 highly exposed Sero-Negative individuals.
The antibody molecule comprises a variable domain conferring antigen specificity and affinity distinct from the heavy chain constant (CH) domains dictating effector functions. We here interrogate this paradigm by evaluating the unique influence of the CH1α domain on epitope specificity and functions...
Main Authors: | Marwa Khamassi, Lin Xu, Julien Rey, Maxence Duchemin, Tahar Bouceba, Pierre Tuffery, Daniela Tudor, Morgane Bomsel |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-12-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1009103 |
Similar Items
-
IgA Targeting Human Immunodeficiency Virus-1 Envelope gp41 Triggers Antibody-Dependent Cellular Cytotoxicity Cross-Clade and Cooperates with gp41-Specific IgG to Increase Cell Lysis
by: Maxence Duchemin, et al.
Published: (2018-03-01) -
The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity
by: Lin Xu, et al.
Published: (2021-02-01) -
Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection
by: Clavel François, et al.
Published: (2008-10-01) -
Randomized Phase I: Safety, Immunogenicity and Mucosal Antiviral Activity in Young Healthy Women Vaccinated with HIV-1 Gp41 P1 Peptide on Virosomes.
by: Geert Leroux-Roels, et al.
Published: (2013-01-01) -
Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA
by: Andréa Cottignies-Calamarte, et al.
Published: (2023-02-01)